ACQUIRED · 2021
Who Acquired HistoTox Labs, Inc.?
Inotiv, Inc. · $22.4M· 7.6× EBITDA
The acquisition
HistoTox Labs, Inc. was acquired by Inotiv, Inc. in 2021 for $22.4M. The deal was priced at 7.6× EBITDA / 2.50× revenue.
HistoTox Labs, Inc. at time of acquisition
Revenue
$9.1M
EBITDA
$2.9M
Deal value
$22.4M
EV / EBITDA
7.6×
Similar laboratory services acquisitions
- GeneSeek (Neogen Animal Genomics) · acquired by Zoetis in 2026 · $160.0M
- CHS Outreach Laboratory Assets · acquired by Laboratory Corporation of America Holdings in 2025 · $194.5M
- OPKO / BioReference Health (Clinical Diagnostics Business) · acquired by Labcorp in 2025 · $192.5M
- Akoya Biosciences, Inc. · acquired by Quanterix Corporation in 2025 · $286.0M
- Enzo Biochem, Inc. · acquired by Battery Ventures in 2025 · $37.0M
Run a valuation for a similar laboratory services business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the laboratory services calculator →More on laboratory services valuations
- Laboratory Services valuation calculator· head-term variant
- Laboratory Services median multiples· real-deal benchmarks
- How to value a laboratory services· long-form guide
Sourced from SEC filings. Full deal page.
Citation: ExitValue.ai. (2021). HistoTox Labs, Inc. acquired by Inotiv, Inc.. https://exitvalue.ai/acquired/histotox-labs-inc